ABOUT MERATIVE
At Merative, we’re building a more connected future in health. One where organizations can see the whole picture – and its pieces – at the highest levels of privacy and security.
We’ve been at the forefront of health innovation for nearly 50 years, pioneering the use of cloud, real-world data and industry-leading AI. Our name is new – but our trailblazing spirit isn’t.
Our team spans the entire health industry and has decades of experience. We get the importance of knowing what it’s like to walk in your shoes – and having a partner who’s with you every step of the way.
FEATURED SOLUTIONS
-
![GettyImages-1327624070-lab-research-development]( "Zelta: A Clinical Trials Platform")
Merative™ Clinical Development is a unified clinical data management and acquisition platform with customizable modules that can be tailored to the unique needs of your clinical trials.
-
![GettyImages-1433732477 zelta]( "Accelerate Your Clinical Trials With Control And Confidence")
Learn about Merative’s new clinical trial solutions business Zelta, which includes both a clinical data management and acquisition platform (formerly Merative Clinical Development), consulting, enablement, and extension services.
CONTACT INFORMATION
Merative
75 Binney Street
Cambridge, MA 02142
UNITED STATES
MERATIVE FEATURED CONTENT
-
![digital-transformation]( "Is Life Sciences Ready For Post-Pandemic Transformation?")
Preparing for the next era of clinical development and therapy commercialization, companies must choose: move forward with innovations spurred by the pandemic or retrench into default practices.
-
![GettyImages-1313298867 cancer patient]( "How A Pandemic Pushed The Gas Pedal On Patient Centricity In Clinical Trials")
Discover why clinical trials are quickly becoming more participant-friendly (and more provider-friendly) through the broader adoption of digital technologies.
-
![GettyImages-1278681737 decentralized trials]( "Optimizing The Decentralization Of Clinical Trials")
Decentralizing aspects of the clinical trial is a natural evolution, with the caveat being that the COVID-19 pandemic helped accelerate that evolutionary process by several years. But learn why decentralization is not necessary for all types of research.
-
![GettyImages-1141201617 DCTs]( "Will DCTs Finally Democratize Clinical Trials?")
The average patient reportedly travels between 50 and 100 miles to reach a clinical site. Consider these points when asking if decentralization is the answer to democratizing clinical trials.
